HOME >> MEDICINE >> NEWS
Researchers seek new hope in old asthma treatment

Theophylline (pronounced theeoffaleen), an asthma medication prescribed since the 1950s, is now being studied for new potential merits. The Effectiveness of Low Dose Theophylline as Add-On Therapy in the Treatment of Asthma or LODO trial is sponsored by the 19 American Lung Association (ALA) Asthma Clinical Research Centers (ACRC) across the country and seeks to enroll over 600 people, age 15 and over, who suffer from persistent asthma symptoms despite treatment. The ALA ACRC at the University of Vermont (UVM), headed by Professor of Medicine and Vermont Lung Center Director Charles Irvin, Ph.D., is the lead study site.

An estimated 26 million Americans have been diagnosed with asthma. About a third of all asthma sufferers are unable to manage their asthma well, Irvin said. The LODO study aims to test its effectiveness as an add-on therapy for this population.

Theophylline is a pill-form asthma treatment classified as a bronchodilator that has been used for over 50 years to help open narrow, inflamed airway passages. The medication became associated with side effects and drug interactions and fell out of favor when newer treatment options became available. Recent studies in such scientific journals as The Lancet and the American Journal of Respiratory Critical Care Medicine suggest that theophylline may have the capacity to reduce airway inflammation and clear away mucus in doses one-quarter to one-third of those needed to open asthmatic passages. So scientists decided to give theophylline another chance.

The LODO study seeks to identify whether or not theophylline can be an effective add-on therapy a booster, so to speak that will produce better overall results for asthmatics. The study will compare the effectiveness and side-effects of low doses of theophylline to montelukast (sold as Singulair), as well as placebo (sugar pill), on asthma patients. During the double-blind study, the patient, the doctor and the research staff
'"/>

Contact: Jennifer Nachbur
jennifer.nachbur@uvm.edu
802-656-7875
University of Vermont
10-May-2002


Page: 1 2

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
3. Researchers close in on breast cancer vaccine
4. Researchers discover link between insulin and Alzheimers
5. Researchers model brains electrical storm during a seizure
6. Researchers track programs success in curbing aggressive behavior
7. Researchers confirm Vioxx nearly doubled cardiovascular risks in cancer prevention study
8. Researchers offer emergency workers a lifeline
9. Researchers discover genetic variant that may explain why women develop M.S. more than men
10. Researchers map the sexual network of an entire high school
11. Researchers hope monkeys can provide new insights into depression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2020)... (PRWEB) , ... May 30, 2020 , ... ... advanced technology and virtual solutions that can meet the needs of a COVID-riddled ... HashCash’s healthcare solutions abide by the necessary compliances and augment the ...
(Date:5/27/2020)... ... May 27, 2020 , ... ... is now manufacturing face shields to be used as personal protective equipment ... These face shields are single use, made to be worn by frontline healthcare ...
(Date:5/26/2020)... ... May 26, 2020 , ... ... which certain infections can impact the brain causing post infectious encephalitis. The ... with Streptococcal Infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) could adversely attack ...
(Date:5/26/2020)... YORK (PRWEB) , ... May 26, 2020 , ... ... to the coronavirus pandemic, medical centers across the United States are joining forces ... health care workers who have worked tirelessly to save lives. #FitForTheFrontLine is a ...
(Date:5/21/2020)... , ... May 21, 2020 , ... ... manufacturer, announces its first milestone to deliver over one million FDA-compliant face shields ... Summit Medical Face Shields meet the critical need for personal protective equipment (PPE) ...
Breaking Medicine News(10 mins):
(Date:5/28/2020)... SPRINGS, Colo. (PRWEB) , ... May 28, 2020 ... ... reduce the time to select the desired recipients. , “Notify.com is an acknowledgement-based ... every message sent to users—whether it be a PUSH notification, SMS text message, ...
(Date:5/27/2020)... ... May 27, 2020 , ... Focus Technology , a leading provider of ... will once again sponsor the American Heart Association’s 2020 Boston Heart Walk, ... third year the firm is sponsoring the AHA event. The sponsorship donation will be ...
(Date:5/26/2020)... ... May 26, 2020 , ... SignatureCare Emergency Center, your friendly ... TX . , The new ER is set to open early June, 2020, and ... at 21315 N SH 130, Bldg.4, Pflugerville, TX. , According to Dr. Aaron ...
Breaking Medicine Technology:
Cached News: